PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 30 filers reported holding PROTEON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $599,000 | 25.51% |
| Abingworth LLP | 2,017,872 | $3,632,000 | 3.04% |
| Pharmstandard International S.A. | 1,165,344 | $2,214,000 | 1.91% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,868,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,332,599 | $2,532,000 | 0.10% |
| Perceptive Advisors | 334,116 | $635,000 | 0.04% |
| Baker Brothers Advisors | 389,394 | $740,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $32,000 | 0.01% |
| FINANCIAL COUNSELORS INC | 50,000 | $95,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 11,499 | $21,000 | 0.00% |